ZA959221B - Cisapride extended release - Google Patents

Cisapride extended release

Info

Publication number
ZA959221B
ZA959221B ZA959221A ZA959221A ZA959221B ZA 959221 B ZA959221 B ZA 959221B ZA 959221 A ZA959221 A ZA 959221A ZA 959221 A ZA959221 A ZA 959221A ZA 959221 B ZA959221 B ZA 959221B
Authority
ZA
South Africa
Prior art keywords
cisapride
extended release
extended
release
cisapride extended
Prior art date
Application number
ZA959221A
Other languages
English (en)
Inventor
Eugene Maria Jozef Jans
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA959221B publication Critical patent/ZA959221B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cereal-Derived Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA959221A 1994-11-02 1995-10-13 Cisapride extended release ZA959221B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94203184 1994-11-02

Publications (1)

Publication Number Publication Date
ZA959221B true ZA959221B (en) 1997-04-30

Family

ID=8217338

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959221A ZA959221B (en) 1994-11-02 1995-10-13 Cisapride extended release

Country Status (29)

Country Link
US (2) US6153623A (xx)
EP (1) EP0789572A1 (xx)
JP (1) JP3182423B2 (xx)
KR (1) KR100255521B1 (xx)
AP (1) AP658A (xx)
AR (1) AR001765A1 (xx)
AU (1) AU704284B2 (xx)
BG (1) BG63244B1 (xx)
BR (1) BR9509565A (xx)
CA (1) CA2203663C (xx)
CZ (1) CZ287844B6 (xx)
EE (1) EE03510B1 (xx)
FI (1) FI971856A0 (xx)
HR (1) HRP950539A2 (xx)
HU (1) HUT77887A (xx)
IL (1) IL115843A0 (xx)
MY (1) MY113092A (xx)
NO (1) NO312538B1 (xx)
NZ (1) NZ295166A (xx)
OA (1) OA10419A (xx)
PL (1) PL181470B1 (xx)
RO (1) RO116042B1 (xx)
RU (1) RU2143890C1 (xx)
SK (1) SK54297A3 (xx)
TR (1) TR199501351A2 (xx)
TW (1) TW466114B (xx)
UA (1) UA50721C2 (xx)
WO (1) WO1996014070A1 (xx)
ZA (1) ZA959221B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
KR19990067264A (ko) * 1995-12-01 1999-08-16 디르크 반테 서방형 시사프라이드
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
AU7888298A (en) * 1997-01-03 1998-07-31 Elan Corporation, Plc Sustained release cisapride minitablet formulation
AU7919398A (en) * 1997-06-11 1998-12-30 Janssen Pharmaceutica N.V. Immediate release ph-independent solid dosage form of (+)- or (-)-cisapride
TW407058B (en) 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
JP4928668B2 (ja) 1999-03-31 2012-05-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 制御放出製剤中の前糊化澱粉
EP1060743A1 (en) * 1999-06-17 2000-12-20 Development Center For Biotechnology Oral cisapride dosage forms with an extended duration
RU2285519C2 (ru) * 2000-09-29 2006-10-20 Солвей Фармасьютикалс Б.В. Фармацевтическая композиция с пролонгированным высвобождением, независимым от ионной силы
DE60228939D1 (de) * 2002-05-21 2008-10-30 Watson Lab Inc Pharmazeutische Zusammensetzung mit verzögerter Freisetzung
US8617596B2 (en) 2006-04-12 2013-12-31 Nippon Soda Co., Ltd. Sustained-release tablet production process
RU2356532C2 (ru) * 2007-06-01 2009-05-27 Открытое Акционерное Общество "Отечественные Лекарства" Фармацевтическая композиция проксодолола с контролируемым высвобождением
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
WO1993018755A1 (en) * 1992-03-25 1993-09-30 Depomed Systems, Incorporated Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
WO1994001112A1 (en) * 1992-07-07 1994-01-20 Sepracor Inc. Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
IL115843A0 (en) 1996-01-31
FI971856A (fi) 1997-04-30
PL319948A1 (en) 1997-09-01
EP0789572A1 (en) 1997-08-20
JP3182423B2 (ja) 2001-07-03
AR001765A1 (es) 1997-12-10
TR199501351A2 (tr) 1996-06-21
FI971856A0 (fi) 1997-04-30
EE9700105A (et) 1997-12-15
BG101401A (en) 1997-12-30
MY113092A (en) 2001-11-30
AU3844795A (en) 1996-05-31
CA2203663A1 (en) 1996-05-17
WO1996014070A1 (en) 1996-05-17
AU704284B2 (en) 1999-04-15
CZ287844B6 (en) 2001-02-14
HUT77887A (hu) 1998-09-28
US6274599B1 (en) 2001-08-14
CZ124497A3 (en) 1997-08-13
RU2143890C1 (ru) 2000-01-10
NO971832L (no) 1997-04-21
JPH09511760A (ja) 1997-11-25
BR9509565A (pt) 1997-09-16
AP658A (en) 1998-08-17
MX9703249A (es) 1997-07-31
CA2203663C (en) 2002-04-30
EE03510B1 (et) 2001-10-15
TW466114B (en) 2001-12-01
NZ295166A (en) 1999-03-29
SK54297A3 (en) 1997-10-08
NO312538B1 (no) 2002-05-27
UA50721C2 (uk) 2002-11-15
AP9700969A0 (en) 1997-04-30
OA10419A (en) 2001-12-06
KR100255521B1 (ko) 2000-05-01
HRP950539A2 (en) 1997-08-31
NO971832D0 (no) 1997-04-21
US6153623A (en) 2000-11-28
PL181470B1 (pl) 2001-07-31
RO116042B1 (ro) 2000-10-30
BG63244B1 (bg) 2001-07-31

Similar Documents

Publication Publication Date Title
DE59704951D1 (en) Plättchenförmiges titandioxidpigment
ZA97171B (en) Novel use
TW407503U (en) Syrings
DE59705192D1 (en) Lcp-blends
DE59700372D1 (en) Blockcopolymere
GB9413957D0 (en) Release devices
ZA959221B (en) Cisapride extended release
DE59707730D1 (en) Peripheralpumpe
DE59704086D1 (en) Twin-dualmode-filter
DE59703905D1 (en) Linearmotorgetriebene transportanlage
GB9606016D0 (en) Novel use
DE59703023D1 (en) Cyclopeptidderivate
DE59702027D1 (en) Bragg-modulator
GB9621990D0 (en) Use
GB9626243D0 (en) Safe re-locker
GB9915929D0 (en) Novel release latch-c-i-p
DE59705556D1 (en) Peripheralpumpe
SK5595A3 (en) Built-in mechanizm
AU131132S (en) Handleset
GB9611192D0 (en) Use
AU131198S (en) Handleset
DE59610178D1 (en) Rotationspumpe
AU131131S (en) Handleset
AU131199S (en) Handleset
GB2317576B (en) Cycles